$ELUT
ELUTIA INC.

2024 Q3 Form 10-Q Financial Statement

#000155837024015748 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $5.922M
YoY Change -3.35%
Cost Of Revenue $3.181M
YoY Change -3.2%
Gross Profit $2.741M
YoY Change -3.52%
Gross Profit Margin 46.29%
Selling, General & Admin $7.510M
YoY Change 35.1%
% of Gross Profit 273.99%
Research & Development $778.0K
YoY Change 39.68%
% of Gross Profit 28.38%
Depreciation & Amortization $862.0K
YoY Change -9.64%
% of Gross Profit 31.45%
Operating Expenses $12.97M
YoY Change 27.02%
Operating Profit -$10.23M
YoY Change 38.79%
Interest Expense $11.52M
YoY Change 695.86%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $1.294M
YoY Change -115.21%
Income Tax $8.000K
% Of Pretax Income 0.62%
Net Earnings $1.286M
YoY Change -113.19%
Net Earnings / Revenue 21.72%
Basic Earnings Per Share $0.03
Diluted Earnings Per Share -$0.33
COMMON SHARES
Basic Shares Outstanding 32.52M
Diluted Shares Outstanding 35.52M

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.74M
YoY Change 77.32%
Cash & Equivalents $25.74M
Short-Term Investments
Other Short-Term Assets $431.0K
YoY Change -94.45%
Inventory $3.633M
Prepaid Expenses
Receivables $2.931M
Other Receivables $4.582M
Total Short-Term Assets $37.32M
YoY Change -4.62%
LONG-TERM ASSETS
Property, Plant & Equipment $693.0K
YoY Change 296.0%
Goodwill
YoY Change
Intangibles $9.123M
YoY Change -27.13%
Long-Term Investments
YoY Change
Other Assets $1.273M
YoY Change 721.29%
Total Long-Term Assets $11.09M
YoY Change -28.24%
TOTAL ASSETS
Total Short-Term Assets $37.32M
Total Long-Term Assets $11.09M
Total Assets $48.41M
YoY Change -11.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.073M
YoY Change 71.27%
Accrued Expenses $5.425M
YoY Change -49.41%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $39.68M
YoY Change -11.31%
LONG-TERM LIABILITIES
Long-Term Debt $22.64M
YoY Change -10.43%
Other Long-Term Liabilities $1.555M
YoY Change 259.12%
Total Long-Term Liabilities $24.20M
YoY Change -5.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $39.68M
Total Long-Term Liabilities $24.20M
Total Liabilities $88.65M
YoY Change 5.46%
SHAREHOLDERS EQUITY
Retained Earnings -$220.5M
YoY Change 32.59%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$40.24M
YoY Change
Total Liabilities & Shareholders Equity $48.41M
YoY Change -11.31%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income $1.286M
YoY Change -113.19%
Depreciation, Depletion And Amortization $862.0K
YoY Change -9.64%
Cash From Operating Activities -$3.427M
YoY Change -33.04%
INVESTING ACTIVITIES
Capital Expenditures $547.0K
YoY Change 827.12%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$547.0K
YoY Change 827.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 11.53M
YoY Change 10.78%
NET CHANGE
Cash From Operating Activities -3.427M
Cash From Investing Activities -547.0K
Cash From Financing Activities 11.53M
Net Change In Cash 7.553M
YoY Change 44.47%
FREE CASH FLOW
Cash From Operating Activities -$3.427M
Capital Expenditures $547.0K
Free Cash Flow -$3.974M
YoY Change -23.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8507000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-45063000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25991000
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001708527
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1400000
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39577
dei Entity Registrant Name
EntityRegistrantName
Elutia Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-4790334
dei Entity Address Address Line1
EntityAddressAddressLine1
12510 Prosperity Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 370
dei Entity Address City Or Town
EntityAddressCityOrTown
Silver Spring
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20904
dei City Area Code
CityAreaCode
240
dei Local Phone Number
LocalPhoneNumber
247-1170
dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
ELUT
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25741000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19276000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2931000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3263000
CY2024Q3 us-gaap Inventory Net
InventoryNet
3633000
CY2023Q4 us-gaap Inventory Net
InventoryNet
3853000
CY2024Q3 us-gaap Loss Contingency Receivable Current
LossContingencyReceivableCurrent
4582000
CY2023Q4 us-gaap Loss Contingency Receivable Current
LossContingencyReceivableCurrent
2696000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
431000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2165000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
37318000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
31253000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
693000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
172000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9123000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11671000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1273000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
332000
CY2024Q3 us-gaap Assets
Assets
48407000
CY2023Q4 us-gaap Assets
Assets
43428000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5073000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3191000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5425000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9485000
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
3321000
CY2024Q3 elut Revenue Interest Obligation Current
RevenueInterestObligationCurrent
4400000
CY2023Q4 elut Revenue Interest Obligation Current
RevenueInterestObligationCurrent
11741000
CY2024Q3 us-gaap Litigation Reserve Current
LitigationReserveCurrent
24289000
CY2023Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
15024000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
491000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
275000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
39678000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
43037000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
22641000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
20356000
CY2024Q3 elut Revenue Interest Obligation Noncurrent
RevenueInterestObligationNoncurrent
6244000
CY2023Q4 elut Revenue Interest Obligation Noncurrent
RevenueInterestObligationNoncurrent
5360000
CY2024Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
18527000
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
12760000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1555000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
515000
CY2024Q3 us-gaap Liabilities
Liabilities
88645000
CY2023Q4 us-gaap Liabilities
Liabilities
82028000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
180260000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
137021000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-220532000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-175644000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-40238000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-38600000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48407000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43428000
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5922000
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6127000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
18907000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
18870000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3181000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3286000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10524000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9943000
CY2024Q3 us-gaap Gross Profit
GrossProfit
2741000
CY2023Q3 us-gaap Gross Profit
GrossProfit
2841000
us-gaap Gross Profit
GrossProfit
8383000
us-gaap Gross Profit
GrossProfit
8927000
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2989000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2802000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9628000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10514000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4521000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2757000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14266000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10137000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
778000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
557000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2951000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3016000
CY2024Q3 us-gaap Legal Fees
LegalFees
4683000
CY2023Q3 us-gaap Legal Fees
LegalFees
4096000
us-gaap Legal Fees
LegalFees
8757000
us-gaap Legal Fees
LegalFees
7278000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
12971000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
10212000
us-gaap Operating Expenses
OperatingExpenses
35602000
us-gaap Operating Expenses
OperatingExpenses
30945000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10230000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7371000
us-gaap Operating Income Loss
OperatingIncomeLoss
-27219000
us-gaap Operating Income Loss
OperatingIncomeLoss
-22018000
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1129000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1448000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
3709000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
4285000
CY2024Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-12653000
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1070000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
15321000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1070000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-758000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1186000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-758000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1294000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8507000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-45063000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25991000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
36000
CY2024Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1286000
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-8519000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-45068000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-26027000
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1228000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
180000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-2315000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
1286000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-9747000
us-gaap Net Income Loss
NetIncomeLoss
-44888000
us-gaap Net Income Loss
NetIncomeLoss
-28342000
CY2024Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
219000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1067000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9747000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-44888000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28342000
CY2024Q3 elut Fair Value Adjustment Of Warrants Dilutive Effect
FairValueAdjustmentOfWarrantsDilutiveEffect
12822000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11755000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-9747000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-44888000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-28342000
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.03
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.50
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.66
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.58
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.33
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.50
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.66
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.58
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.07
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.01
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.14
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.72
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.65
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.72
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32520134
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17017610
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27132216
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16464262
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35520938
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17017610
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27132216
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27132216
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16464262
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16464262
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-64338000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7000
CY2024Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
21635000
CY2024Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
85000
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-688000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1775000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
1286000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-40238000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-22128000
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
72000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
615000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-9747000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-29473000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-38600000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
27743000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
155000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-1010000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6683000
us-gaap Net Income Loss
NetIncomeLoss
-44888000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-40238000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5033000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
219000
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-19000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1987000
us-gaap Net Income Loss
NetIncomeLoss
-28342000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-29473000
us-gaap Profit Loss
ProfitLoss
-44888000
us-gaap Profit Loss
ProfitLoss
-28342000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2588000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2854000
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
180000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
15321000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1070000
elut Gain Loss On Revaluation Of Revenue Interest Obligation And Other
GainLossOnRevaluationOfRevenueInterestObligationAndOther
1443000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
162000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
161000
elut Interest Expense Recorded As Additional Revenue Interest Obligation
InterestExpenseRecordedAsAdditionalRevenueInterestObligation
2086000
elut Interest Expense Recorded As Additional Revenue Interest Obligation
InterestExpenseRecordedAsAdditionalRevenueInterestObligation
2473000
us-gaap Share Based Compensation
ShareBasedCompensation
6683000
us-gaap Share Based Compensation
ShareBasedCompensation
1987000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
251000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
590000
elut Losses On Product Recall And Market Withdrawal
LossesOnProductRecallAndMarketWithdrawal
1984000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-81000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1045000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-220000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2490000
us-gaap Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
1886000
us-gaap Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
-6361000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2171000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1609000
elut Increase Decrease In Accounts Payable And Accrued Expenses And Payables To Tissue Suppliers
IncreaseDecreaseInAccountsPayableAndAccruedExpensesAndPayablesToTissueSuppliers
-984000
elut Increase Decrease In Accounts Payable And Accrued Expenses And Payables To Tissue Suppliers
IncreaseDecreaseInAccountsPayableAndAccruedExpensesAndPayablesToTissueSuppliers
1513000
elut Increase Decrease Contingent Liability
IncreaseDecreaseContingentLiability
9265000
elut Increase Decrease Contingent Liability
IncreaseDecreaseContingentLiability
-1658000
elut Increase Decrease In Contract With Customer Liability And Other Liabilities
IncreaseDecreaseInContractWithCustomerLiabilityAndOtherLiabilities
153000
elut Increase Decrease In Contract With Customer Liability And Other Liabilities
IncreaseDecreaseInContractWithCustomerLiabilityAndOtherLiabilities
305000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10400000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12678000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
180000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
560000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
329000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-380000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-329000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12390000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10335000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2000000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
15725000
elut Payments On Revenue Interest Obligation
PaymentsOnRevenueInterestObligation
6300000
elut Repayments Of Insurance Premium Financings
RepaymentsOfInsurancePremiumFinancings
1721000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1011000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
19000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
162000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
219000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17245000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10535000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
6465000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2472000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19276000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16989000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25741000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14517000
us-gaap Interest Paid Net
InterestPaidNet
4421000
us-gaap Interest Paid Net
InterestPaidNet
1696000
elut Fair Value Of Warrants Issued
FairValueOfWarrantsIssued
2464000
elut Operating Lease Right Of Use Asset Extensions
OperatingLeaseRightOfUseAssetExtensions
1379000
elut Common Stock Issued Upon Conversion Warrants
CommonStockIssuedUponConversionWarrants
17576000
us-gaap Net Income Loss
NetIncomeLoss
-44900000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-220500000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10400000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Reclassifications</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Certain reclassifications have been made to prior year amounts to conform to current year financial statement presentation. </p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates and assumptions relating to inventories, receivables, long-lived assets, the valuation of stock-based awards, the valuation of the revenue interest obligation, the valuation of the warrant liability, the contingent liabilities for legal proceedings and deferred income taxes are made at the end of each financial reporting period by management. Management continually re-evaluates its estimates, judgments and assumptions, and management's evaluation could change. Actual results could differ from those estimates.</p>
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1400000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
200000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
600000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
700000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
100000
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2023Q3 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2024Q3 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash. The Company’s cash balances with individual institutions may at times exceed the federally insured limits. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">There were two customers that represented 15% and 10%, respectively, of the Company’s net sales for the nine months ended September 30, 2024 and 15% and 8% of the Company’s net sales for the three months ended September 30, 2024. Additionally, there was one customer that represented 14% of the Company’s accounts receivable as of September 30, 2024. </p>
us-gaap Depreciation And Amortization Discontinued Operations
DepreciationAndAmortizationDiscontinuedOperations
213000
elut Stock Based Compensation Discontinued Operations
StockBasedCompensationDiscontinuedOperations
115000
elut Increase Decrease In Accounts Receivable Discontinued Operations
IncreaseDecreaseInAccountsReceivableDiscontinuedOperations
-745000
elut Increase Decrease In Inventory Discontinued Operations
IncreaseDecreaseInInventoryDiscontinuedOperations
-1757000
elut Increase Decrease In Prepaid Expenses Other Discontinued Operations
IncreaseDecreaseInPrepaidExpensesOtherDiscontinuedOperations
326000
elut Increase Decrease In Accounts Payable Accrued Liabilities And Other Discontinued Operations
IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndOtherDiscontinuedOperations
-920000
elut Increase Decrease In Obligations To Tissue Suppliers Discontinued Operations
IncreaseDecreaseInObligationsToTissueSuppliersDiscontinuedOperations
-857000
us-gaap Capital Expenditure Discontinued Operations
CapitalExpenditureDiscontinuedOperations
287000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1501193
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.37
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1790654
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.59
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1960
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.61
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
59433
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
10.21
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3230454
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.23
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
621000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1644088
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
5.87
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y1M6D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
353000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.38
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1775000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
566000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6683000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1872000
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
555000
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
242000
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
758000
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
286000
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2320000
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3325000
CY2024Q3 us-gaap Inventory Net
InventoryNet
3633000
CY2023Q4 us-gaap Inventory Net
InventoryNet
3853000
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
22641000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
23677000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3321000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
22641000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
20356000
CY2024Q3 us-gaap Loss Contingency Receivable
LossContingencyReceivable
4600000
CY2024Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1286000
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-8519000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-45068000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-26027000
CY2024Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
219000
CY2024Q3 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
1067000
CY2023Q3 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-8519000
us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-45068000
us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-26027000
CY2023Q3 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
-1228000
us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
180000
us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
-2315000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1067000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9747000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-44888000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28342000
CY2024Q3 elut Fair Value Adjustment Of Warrants Dilutive Effect
FairValueAdjustmentOfWarrantsDilutiveEffect
12822000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11755000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-9747000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-44888000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-28342000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32520134
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17017610
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27132216
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16464262
CY2024Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
3000804
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35520938
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17017610
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27132216
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16464262
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.03
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.50
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.66
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.58
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.33
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.50
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.66
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.58
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.07
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.01
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.14
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.72
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.65
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.72
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8855177
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13742546
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9821765
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13742546
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5922000
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6127000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
18907000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
18870000
CY2024Q3 elut Gross Profit Before Intangible Asset Amortization
GrossProfitBeforeIntangibleAssetAmortization
3590000
CY2023Q3 elut Gross Profit Before Intangible Asset Amortization
GrossProfitBeforeIntangibleAssetAmortization
3690000
elut Gross Profit Before Intangible Asset Amortization
GrossProfitBeforeIntangibleAssetAmortization
10930000
elut Gross Profit Before Intangible Asset Amortization
GrossProfitBeforeIntangibleAssetAmortization
11474000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
849000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
849000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2547000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2547000
CY2024Q3 us-gaap Gross Profit
GrossProfit
2741000
CY2023Q3 us-gaap Gross Profit
GrossProfit
2841000
us-gaap Gross Profit
GrossProfit
8383000
us-gaap Gross Profit
GrossProfit
8927000
CY2024Q3 elut Gross Profit Before Intangible Asset Amortization
GrossProfitBeforeIntangibleAssetAmortization
3590000
CY2023Q3 elut Gross Profit Before Intangible Asset Amortization
GrossProfitBeforeIntangibleAssetAmortization
3690000
elut Gross Profit Before Intangible Asset Amortization
GrossProfitBeforeIntangibleAssetAmortization
10930000
elut Gross Profit Before Intangible Asset Amortization
GrossProfitBeforeIntangibleAssetAmortization
11474000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
849000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
849000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2547000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2547000
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2989000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2802000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9628000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10514000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4521000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2757000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14266000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10137000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
778000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
557000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2951000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3016000
CY2024Q3 us-gaap Legal Fees
LegalFees
4683000
CY2023Q3 us-gaap Legal Fees
LegalFees
4096000
us-gaap Legal Fees
LegalFees
8757000
us-gaap Legal Fees
LegalFees
7278000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10230000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7371000
us-gaap Operating Income Loss
OperatingIncomeLoss
-27219000
us-gaap Operating Income Loss
OperatingIncomeLoss
-22018000
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1129000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1448000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
3709000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
4285000
CY2024Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-12653000
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1070000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
15321000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1070000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-758000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1186000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-758000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1294000

Files In Submission

Name View Source Status
0001558370-24-015748-index-headers.html Edgar Link pending
0001558370-24-015748-index.html Edgar Link pending
0001558370-24-015748.txt Edgar Link pending
0001558370-24-015748-xbrl.zip Edgar Link pending
elut-20240930.xsd Edgar Link pending
elut-20240930x10q.htm Edgar Link pending
elut-20240930xex31d1.htm Edgar Link pending
elut-20240930xex31d2.htm Edgar Link pending
elut-20240930xex32d1.htm Edgar Link pending
elut-20240930xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
elut-20240930_def.xml Edgar Link unprocessable
elut-20240930_lab.xml Edgar Link unprocessable
elut-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
elut-20240930x10q_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
elut-20240930_cal.xml Edgar Link unprocessable